Aim: A clinical and epidemiological investigation of a facial hyperpigmentation disease. Material and methods: A total of 100 patients diagnosed with facehyperpigmentationwereincluded in this research. Upon receiving ethical permission from the institutional ethics committee and gaining agreement from the patient, all patients seeking treatment for face pigmentation problems in the out-patient department were included in the research. Following the collection of demographic data, a comprehensive clinical history was recorded, including information on the age at which the condition was first seen, the age at which symptoms began, the length of time the illness has been present, and any relevant family medical history. Results: The average age of the participants in the research was 29.01±3.25 years. Among the 100 patients, the majority, namely 75%, were females, while just 25% were men. A higher proportion of females was observed, with a female to male ratio of 3:1. The predominant form of face hyperpigmentation seen in our research was melasma, accounting for 52% of cases. Post inflammatory hyperpigmentation (PIH) occurs in 15% of cases, whereas ephilides occur in 7%. Rehl's melanosis and drug-induced melanosis were seen in 6% of the patients each. Thirteen percent of patients had thyroid problems. In our analysis, post-inflammatory hyperpigmentation accounted for 13% of cases with changed face pigmentation, making it the second most prevalent cause. There was a small majority of females. The primary cause in the majority of cases was acne vulgaris. In our research, 14% of patients had a family history of PIH. Conclusion: The most often reported age group was between 20 to 40 years old, with a higher proportion of females. The most frequently detected types of face hyperpigmentation were melasma (52%), post-inflammatory hyperpigmentation (15%), and ephilides (7%).